ANNALS OF THE RHEUMATIC DISEASES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=566405, encodeId=eff1566405fe, content=目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08fb1710649, createdName=花开的好香, createdTime=Fri Feb 01 18:03:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551821, encodeId=9d10551821c1, content=请教各位大神，case report这个杂志收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7141702918, createdName=1de85eb4m05(暂无匿称), createdTime=Mon Jan 22 11:46:00 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535420, encodeId=239953542010, content=多投哦135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%13581863701(暂无匿称) 2016-11-21 09:01:00 发表: 直接被拒了告诉我直接不被拒的可能性只有15%, beContent=135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/48d1fec880a796cc2ad284d7b18e6017.jpg, createdBy=43e51704272, createdName=九天., createdTime=Tue Apr 11 00:00:00 CST 2017, time=2017-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530604, encodeId=845d53060437, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：欧洲抗风湿病联盟的官方期刊，学科排名第一，内容涵盖肌肉骨骼、关节炎和结缔组织疾病等所有风湿病学相关的基础、临床和转化研究。?收稿率：12% （原创研究文章）出版速度：投稿至初步决定：平均17天?（原创研究文章） ? ? ? ? ? ? ? ? ? ? 接收至发表：平均13天（线上发表）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 18:08:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530211, encodeId=c07c530211cb, content=12.38, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=524, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Mon Dec 05 07:33:00 CST 2016, time=2016-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529608, encodeId=4c9d52960850, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：直接被拒了告诉我直接不被拒的可能性只有15%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Mon Nov 21 09:01:00 CST 2016, time=2016-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526107, encodeId=cadf52610e5c, content=没有勇气投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Aug 21 07:18:00 CST 2016, time=2016-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832971, encodeId=e6f78329e17c, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：风湿科全球排名第一的刊。 一审17天，接收后13天online。看了看，有中国编委，中国文章也每年都有不少，中国作者可以的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Thu Aug 04 14:36:56 CST 2016, time=2016-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522639, encodeId=85c452263986, content=审稿速度:3.0 经验分享：顶级杂志，严谨求实, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Fri May 20 03:05:00 CST 2016, time=2016-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517574, encodeId=6cb251e5748d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过两篇，一篇2天就拒了，第二篇一审17天，建议大修，审稿意见很细致，改后二审20天，接收,两周后online. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=573, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95ec1668172, createdName=面膜大侠, createdTime=Mon Dec 14 09:41:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]

2019-02-01 花开的好香

目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。

262 0

[GetPortalCommentsPageByObjectIdResponse(id=566405, encodeId=eff1566405fe, content=目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08fb1710649, createdName=花开的好香, createdTime=Fri Feb 01 18:03:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551821, encodeId=9d10551821c1, content=请教各位大神，case report这个杂志收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7141702918, createdName=1de85eb4m05(暂无匿称), createdTime=Mon Jan 22 11:46:00 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535420, encodeId=239953542010, content=多投哦135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%13581863701(暂无匿称) 2016-11-21 09:01:00 发表: 直接被拒了告诉我直接不被拒的可能性只有15%, beContent=135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/48d1fec880a796cc2ad284d7b18e6017.jpg, createdBy=43e51704272, createdName=九天., createdTime=Tue Apr 11 00:00:00 CST 2017, time=2017-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530604, encodeId=845d53060437, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：欧洲抗风湿病联盟的官方期刊，学科排名第一，内容涵盖肌肉骨骼、关节炎和结缔组织疾病等所有风湿病学相关的基础、临床和转化研究。?收稿率：12% （原创研究文章）出版速度：投稿至初步决定：平均17天?（原创研究文章） ? ? ? ? ? ? ? ? ? ? 接收至发表：平均13天（线上发表）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 18:08:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530211, encodeId=c07c530211cb, content=12.38, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=524, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Mon Dec 05 07:33:00 CST 2016, time=2016-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529608, encodeId=4c9d52960850, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：直接被拒了告诉我直接不被拒的可能性只有15%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Mon Nov 21 09:01:00 CST 2016, time=2016-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526107, encodeId=cadf52610e5c, content=没有勇气投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Aug 21 07:18:00 CST 2016, time=2016-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832971, encodeId=e6f78329e17c, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：风湿科全球排名第一的刊。 一审17天，接收后13天online。看了看，有中国编委，中国文章也每年都有不少，中国作者可以的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Thu Aug 04 14:36:56 CST 2016, time=2016-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522639, encodeId=85c452263986, content=审稿速度:3.0 经验分享：顶级杂志，严谨求实, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Fri May 20 03:05:00 CST 2016, time=2016-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517574, encodeId=6cb251e5748d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过两篇，一篇2天就拒了，第二篇一审17天，建议大修，审稿意见很细致，改后二审20天，接收,两周后online. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=573, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95ec1668172, createdName=面膜大侠, createdTime=Mon Dec 14 09:41:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]

2018-01-22 1de85eb4m05(暂无匿称)

请教各位大神，case report这个杂志收吗？

430 0

[GetPortalCommentsPageByObjectIdResponse(id=566405, encodeId=eff1566405fe, content=目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08fb1710649, createdName=花开的好香, createdTime=Fri Feb 01 18:03:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551821, encodeId=9d10551821c1, content=请教各位大神，case report这个杂志收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7141702918, createdName=1de85eb4m05(暂无匿称), createdTime=Mon Jan 22 11:46:00 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535420, encodeId=239953542010, content=多投哦135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%13581863701(暂无匿称) 2016-11-21 09:01:00 发表: 直接被拒了告诉我直接不被拒的可能性只有15%, beContent=135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/48d1fec880a796cc2ad284d7b18e6017.jpg, createdBy=43e51704272, createdName=九天., createdTime=Tue Apr 11 00:00:00 CST 2017, time=2017-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530604, encodeId=845d53060437, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：欧洲抗风湿病联盟的官方期刊，学科排名第一，内容涵盖肌肉骨骼、关节炎和结缔组织疾病等所有风湿病学相关的基础、临床和转化研究。?收稿率：12% （原创研究文章）出版速度：投稿至初步决定：平均17天?（原创研究文章） ? ? ? ? ? ? ? ? ? ? 接收至发表：平均13天（线上发表）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 18:08:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530211, encodeId=c07c530211cb, content=12.38, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=524, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Mon Dec 05 07:33:00 CST 2016, time=2016-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529608, encodeId=4c9d52960850, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：直接被拒了告诉我直接不被拒的可能性只有15%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Mon Nov 21 09:01:00 CST 2016, time=2016-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526107, encodeId=cadf52610e5c, content=没有勇气投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Aug 21 07:18:00 CST 2016, time=2016-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832971, encodeId=e6f78329e17c, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：风湿科全球排名第一的刊。 一审17天，接收后13天online。看了看，有中国编委，中国文章也每年都有不少，中国作者可以的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Thu Aug 04 14:36:56 CST 2016, time=2016-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522639, encodeId=85c452263986, content=审稿速度:3.0 经验分享：顶级杂志，严谨求实, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Fri May 20 03:05:00 CST 2016, time=2016-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517574, encodeId=6cb251e5748d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过两篇，一篇2天就拒了，第二篇一审17天，建议大修，审稿意见很细致，改后二审20天，接收,两周后online. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=573, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95ec1668172, createdName=面膜大侠, createdTime=Mon Dec 14 09:41:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]

2017-04-11 九天.

多投哦135****3701(暂无匿称) 2016-11-21 发表::
接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%13581863701(暂无匿称) 2016-11-21 09:01:00 发表:
直接被拒了告诉我直接不被拒的可能性只有15%

135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%

306 0

[GetPortalCommentsPageByObjectIdResponse(id=566405, encodeId=eff1566405fe, content=目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08fb1710649, createdName=花开的好香, createdTime=Fri Feb 01 18:03:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551821, encodeId=9d10551821c1, content=请教各位大神，case report这个杂志收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7141702918, createdName=1de85eb4m05(暂无匿称), createdTime=Mon Jan 22 11:46:00 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535420, encodeId=239953542010, content=多投哦135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%13581863701(暂无匿称) 2016-11-21 09:01:00 发表: 直接被拒了告诉我直接不被拒的可能性只有15%, beContent=135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/48d1fec880a796cc2ad284d7b18e6017.jpg, createdBy=43e51704272, createdName=九天., createdTime=Tue Apr 11 00:00:00 CST 2017, time=2017-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530604, encodeId=845d53060437, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：欧洲抗风湿病联盟的官方期刊，学科排名第一，内容涵盖肌肉骨骼、关节炎和结缔组织疾病等所有风湿病学相关的基础、临床和转化研究。?收稿率：12% （原创研究文章）出版速度：投稿至初步决定：平均17天?（原创研究文章） ? ? ? ? ? ? ? ? ? ? 接收至发表：平均13天（线上发表）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 18:08:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530211, encodeId=c07c530211cb, content=12.38, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=524, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Mon Dec 05 07:33:00 CST 2016, time=2016-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529608, encodeId=4c9d52960850, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：直接被拒了告诉我直接不被拒的可能性只有15%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Mon Nov 21 09:01:00 CST 2016, time=2016-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526107, encodeId=cadf52610e5c, content=没有勇气投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Aug 21 07:18:00 CST 2016, time=2016-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832971, encodeId=e6f78329e17c, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：风湿科全球排名第一的刊。 一审17天，接收后13天online。看了看，有中国编委，中国文章也每年都有不少，中国作者可以的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Thu Aug 04 14:36:56 CST 2016, time=2016-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522639, encodeId=85c452263986, content=审稿速度:3.0 经验分享：顶级杂志，严谨求实, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Fri May 20 03:05:00 CST 2016, time=2016-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517574, encodeId=6cb251e5748d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过两篇，一篇2天就拒了，第二篇一审17天，建议大修，审稿意见很细致，改后二审20天，接收,两周后online. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=573, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95ec1668172, createdName=面膜大侠, createdTime=Mon Dec 14 09:41:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]

2016-12-14 HawkingS2832

审稿速度:1.0 | 投稿命中率:25.0
经验分享：欧洲抗风湿病联盟的官方期刊，学科排名第一，内容涵盖肌肉骨骼、关节炎和结缔组织疾病等所有风湿病学相关的基础、临床和转化研究。?收稿率：12% （原创研究文章）出版速度：投稿至初步决定：平均17天?（原创研究文章） ? ? ? ? ? ? ? ? ? ? 接收至发表：平均13天（线上发表）

491 0

[GetPortalCommentsPageByObjectIdResponse(id=566405, encodeId=eff1566405fe, content=目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08fb1710649, createdName=花开的好香, createdTime=Fri Feb 01 18:03:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551821, encodeId=9d10551821c1, content=请教各位大神，case report这个杂志收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7141702918, createdName=1de85eb4m05(暂无匿称), createdTime=Mon Jan 22 11:46:00 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535420, encodeId=239953542010, content=多投哦135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%13581863701(暂无匿称) 2016-11-21 09:01:00 发表: 直接被拒了告诉我直接不被拒的可能性只有15%, beContent=135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/48d1fec880a796cc2ad284d7b18e6017.jpg, createdBy=43e51704272, createdName=九天., createdTime=Tue Apr 11 00:00:00 CST 2017, time=2017-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530604, encodeId=845d53060437, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：欧洲抗风湿病联盟的官方期刊，学科排名第一，内容涵盖肌肉骨骼、关节炎和结缔组织疾病等所有风湿病学相关的基础、临床和转化研究。?收稿率：12% （原创研究文章）出版速度：投稿至初步决定：平均17天?（原创研究文章） ? ? ? ? ? ? ? ? ? ? 接收至发表：平均13天（线上发表）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 18:08:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530211, encodeId=c07c530211cb, content=12.38, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=524, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Mon Dec 05 07:33:00 CST 2016, time=2016-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529608, encodeId=4c9d52960850, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：直接被拒了告诉我直接不被拒的可能性只有15%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Mon Nov 21 09:01:00 CST 2016, time=2016-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526107, encodeId=cadf52610e5c, content=没有勇气投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Aug 21 07:18:00 CST 2016, time=2016-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832971, encodeId=e6f78329e17c, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：风湿科全球排名第一的刊。 一审17天，接收后13天online。看了看，有中国编委，中国文章也每年都有不少，中国作者可以的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Thu Aug 04 14:36:56 CST 2016, time=2016-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522639, encodeId=85c452263986, content=审稿速度:3.0 经验分享：顶级杂志，严谨求实, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Fri May 20 03:05:00 CST 2016, time=2016-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517574, encodeId=6cb251e5748d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过两篇，一篇2天就拒了，第二篇一审17天，建议大修，审稿意见很细致，改后二审20天，接收,两周后online. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=573, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95ec1668172, createdName=面膜大侠, createdTime=Mon Dec 14 09:41:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]

2016-12-05 镱鉎鉌釚

12.38

524 0

[GetPortalCommentsPageByObjectIdResponse(id=566405, encodeId=eff1566405fe, content=目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08fb1710649, createdName=花开的好香, createdTime=Fri Feb 01 18:03:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551821, encodeId=9d10551821c1, content=请教各位大神，case report这个杂志收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7141702918, createdName=1de85eb4m05(暂无匿称), createdTime=Mon Jan 22 11:46:00 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535420, encodeId=239953542010, content=多投哦135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%13581863701(暂无匿称) 2016-11-21 09:01:00 发表: 直接被拒了告诉我直接不被拒的可能性只有15%, beContent=135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/48d1fec880a796cc2ad284d7b18e6017.jpg, createdBy=43e51704272, createdName=九天., createdTime=Tue Apr 11 00:00:00 CST 2017, time=2017-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530604, encodeId=845d53060437, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：欧洲抗风湿病联盟的官方期刊，学科排名第一，内容涵盖肌肉骨骼、关节炎和结缔组织疾病等所有风湿病学相关的基础、临床和转化研究。?收稿率：12% （原创研究文章）出版速度：投稿至初步决定：平均17天?（原创研究文章） ? ? ? ? ? ? ? ? ? ? 接收至发表：平均13天（线上发表）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 18:08:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530211, encodeId=c07c530211cb, content=12.38, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=524, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Mon Dec 05 07:33:00 CST 2016, time=2016-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529608, encodeId=4c9d52960850, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：直接被拒了告诉我直接不被拒的可能性只有15%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Mon Nov 21 09:01:00 CST 2016, time=2016-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526107, encodeId=cadf52610e5c, content=没有勇气投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Aug 21 07:18:00 CST 2016, time=2016-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832971, encodeId=e6f78329e17c, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：风湿科全球排名第一的刊。 一审17天，接收后13天online。看了看，有中国编委，中国文章也每年都有不少，中国作者可以的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Thu Aug 04 14:36:56 CST 2016, time=2016-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522639, encodeId=85c452263986, content=审稿速度:3.0 经验分享：顶级杂志，严谨求实, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Fri May 20 03:05:00 CST 2016, time=2016-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517574, encodeId=6cb251e5748d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过两篇，一篇2天就拒了，第二篇一审17天，建议大修，审稿意见很细致，改后二审20天，接收,两周后online. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=573, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95ec1668172, createdName=面膜大侠, createdTime=Mon Dec 14 09:41:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]

2016-11-21 1e18b22bm01(暂无匿称)

审稿速度:1.0 | 投稿命中率:5.0
经验分享：直接被拒了告诉我直接不被拒的可能性只有15%

479 0

[GetPortalCommentsPageByObjectIdResponse(id=566405, encodeId=eff1566405fe, content=目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08fb1710649, createdName=花开的好香, createdTime=Fri Feb 01 18:03:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551821, encodeId=9d10551821c1, content=请教各位大神，case report这个杂志收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7141702918, createdName=1de85eb4m05(暂无匿称), createdTime=Mon Jan 22 11:46:00 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535420, encodeId=239953542010, content=多投哦135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%13581863701(暂无匿称) 2016-11-21 09:01:00 发表: 直接被拒了告诉我直接不被拒的可能性只有15%, beContent=135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/48d1fec880a796cc2ad284d7b18e6017.jpg, createdBy=43e51704272, createdName=九天., createdTime=Tue Apr 11 00:00:00 CST 2017, time=2017-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530604, encodeId=845d53060437, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：欧洲抗风湿病联盟的官方期刊，学科排名第一，内容涵盖肌肉骨骼、关节炎和结缔组织疾病等所有风湿病学相关的基础、临床和转化研究。?收稿率：12% （原创研究文章）出版速度：投稿至初步决定：平均17天?（原创研究文章） ? ? ? ? ? ? ? ? ? ? 接收至发表：平均13天（线上发表）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 18:08:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530211, encodeId=c07c530211cb, content=12.38, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=524, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Mon Dec 05 07:33:00 CST 2016, time=2016-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529608, encodeId=4c9d52960850, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：直接被拒了告诉我直接不被拒的可能性只有15%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Mon Nov 21 09:01:00 CST 2016, time=2016-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526107, encodeId=cadf52610e5c, content=没有勇气投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Aug 21 07:18:00 CST 2016, time=2016-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832971, encodeId=e6f78329e17c, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：风湿科全球排名第一的刊。 一审17天，接收后13天online。看了看，有中国编委，中国文章也每年都有不少，中国作者可以的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Thu Aug 04 14:36:56 CST 2016, time=2016-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522639, encodeId=85c452263986, content=审稿速度:3.0 经验分享：顶级杂志，严谨求实, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Fri May 20 03:05:00 CST 2016, time=2016-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517574, encodeId=6cb251e5748d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过两篇，一篇2天就拒了，第二篇一审17天，建议大修，审稿意见很细致，改后二审20天，接收,两周后online. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=573, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95ec1668172, createdName=面膜大侠, createdTime=Mon Dec 14 09:41:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]

2016-08-21 jyzxjiangqin

没有勇气投稿！

510 0

[GetPortalCommentsPageByObjectIdResponse(id=566405, encodeId=eff1566405fe, content=目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08fb1710649, createdName=花开的好香, createdTime=Fri Feb 01 18:03:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551821, encodeId=9d10551821c1, content=请教各位大神，case report这个杂志收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7141702918, createdName=1de85eb4m05(暂无匿称), createdTime=Mon Jan 22 11:46:00 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535420, encodeId=239953542010, content=多投哦135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%13581863701(暂无匿称) 2016-11-21 09:01:00 发表: 直接被拒了告诉我直接不被拒的可能性只有15%, beContent=135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/48d1fec880a796cc2ad284d7b18e6017.jpg, createdBy=43e51704272, createdName=九天., createdTime=Tue Apr 11 00:00:00 CST 2017, time=2017-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530604, encodeId=845d53060437, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：欧洲抗风湿病联盟的官方期刊，学科排名第一，内容涵盖肌肉骨骼、关节炎和结缔组织疾病等所有风湿病学相关的基础、临床和转化研究。?收稿率：12% （原创研究文章）出版速度：投稿至初步决定：平均17天?（原创研究文章） ? ? ? ? ? ? ? ? ? ? 接收至发表：平均13天（线上发表）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 18:08:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530211, encodeId=c07c530211cb, content=12.38, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=524, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Mon Dec 05 07:33:00 CST 2016, time=2016-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529608, encodeId=4c9d52960850, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：直接被拒了告诉我直接不被拒的可能性只有15%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Mon Nov 21 09:01:00 CST 2016, time=2016-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526107, encodeId=cadf52610e5c, content=没有勇气投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Aug 21 07:18:00 CST 2016, time=2016-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832971, encodeId=e6f78329e17c, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：风湿科全球排名第一的刊。 一审17天，接收后13天online。看了看，有中国编委，中国文章也每年都有不少，中国作者可以的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Thu Aug 04 14:36:56 CST 2016, time=2016-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522639, encodeId=85c452263986, content=审稿速度:3.0 经验分享：顶级杂志，严谨求实, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Fri May 20 03:05:00 CST 2016, time=2016-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517574, encodeId=6cb251e5748d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过两篇，一篇2天就拒了，第二篇一审17天，建议大修，审稿意见很细致，改后二审20天，接收,两周后online. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=573, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95ec1668172, createdName=面膜大侠, createdTime=Mon Dec 14 09:41:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]

2016-08-04 ms8494960720180498

审稿速度:3.0 | 投稿命中率:75.0
经验分享：风湿科全球排名第一的刊。
一审17天，接收后13天online。看了看，有中国编委，中国文章也每年都有不少，中国作者可以的。

122 0

[GetPortalCommentsPageByObjectIdResponse(id=566405, encodeId=eff1566405fe, content=目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08fb1710649, createdName=花开的好香, createdTime=Fri Feb 01 18:03:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551821, encodeId=9d10551821c1, content=请教各位大神，case report这个杂志收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7141702918, createdName=1de85eb4m05(暂无匿称), createdTime=Mon Jan 22 11:46:00 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535420, encodeId=239953542010, content=多投哦135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%13581863701(暂无匿称) 2016-11-21 09:01:00 发表: 直接被拒了告诉我直接不被拒的可能性只有15%, beContent=135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/48d1fec880a796cc2ad284d7b18e6017.jpg, createdBy=43e51704272, createdName=九天., createdTime=Tue Apr 11 00:00:00 CST 2017, time=2017-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530604, encodeId=845d53060437, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：欧洲抗风湿病联盟的官方期刊，学科排名第一，内容涵盖肌肉骨骼、关节炎和结缔组织疾病等所有风湿病学相关的基础、临床和转化研究。?收稿率：12% （原创研究文章）出版速度：投稿至初步决定：平均17天?（原创研究文章） ? ? ? ? ? ? ? ? ? ? 接收至发表：平均13天（线上发表）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 18:08:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530211, encodeId=c07c530211cb, content=12.38, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=524, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Mon Dec 05 07:33:00 CST 2016, time=2016-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529608, encodeId=4c9d52960850, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：直接被拒了告诉我直接不被拒的可能性只有15%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Mon Nov 21 09:01:00 CST 2016, time=2016-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526107, encodeId=cadf52610e5c, content=没有勇气投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Aug 21 07:18:00 CST 2016, time=2016-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832971, encodeId=e6f78329e17c, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：风湿科全球排名第一的刊。 一审17天，接收后13天online。看了看，有中国编委，中国文章也每年都有不少，中国作者可以的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Thu Aug 04 14:36:56 CST 2016, time=2016-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522639, encodeId=85c452263986, content=审稿速度:3.0 经验分享：顶级杂志，严谨求实, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Fri May 20 03:05:00 CST 2016, time=2016-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517574, encodeId=6cb251e5748d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过两篇，一篇2天就拒了，第二篇一审17天，建议大修，审稿意见很细致，改后二审20天，接收,两周后online. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=573, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95ec1668172, createdName=面膜大侠, createdTime=Mon Dec 14 09:41:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]

2016-05-20 arlian1977

审稿速度:3.0
经验分享：顶级杂志，严谨求实

385 0

[GetPortalCommentsPageByObjectIdResponse(id=566405, encodeId=eff1566405fe, content=目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08fb1710649, createdName=花开的好香, createdTime=Fri Feb 01 18:03:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551821, encodeId=9d10551821c1, content=请教各位大神，case report这个杂志收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7141702918, createdName=1de85eb4m05(暂无匿称), createdTime=Mon Jan 22 11:46:00 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535420, encodeId=239953542010, content=多投哦135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%13581863701(暂无匿称) 2016-11-21 09:01:00 发表: 直接被拒了告诉我直接不被拒的可能性只有15%, beContent=135****3701(暂无匿称) 2016-11-21 发表:: 接收率：约5% 审稿时间：约1个月直接被拒了告诉我直接不被拒的可能性只有15%, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/48d1fec880a796cc2ad284d7b18e6017.jpg, createdBy=43e51704272, createdName=九天., createdTime=Tue Apr 11 00:00:00 CST 2017, time=2017-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530604, encodeId=845d53060437, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：欧洲抗风湿病联盟的官方期刊，学科排名第一，内容涵盖肌肉骨骼、关节炎和结缔组织疾病等所有风湿病学相关的基础、临床和转化研究。?收稿率：12% （原创研究文章）出版速度：投稿至初步决定：平均17天?（原创研究文章） ? ? ? ? ? ? ? ? ? ? 接收至发表：平均13天（线上发表）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 18:08:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530211, encodeId=c07c530211cb, content=12.38, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=524, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Mon Dec 05 07:33:00 CST 2016, time=2016-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529608, encodeId=4c9d52960850, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：直接被拒了告诉我直接不被拒的可能性只有15%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Mon Nov 21 09:01:00 CST 2016, time=2016-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526107, encodeId=cadf52610e5c, content=没有勇气投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Aug 21 07:18:00 CST 2016, time=2016-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832971, encodeId=e6f78329e17c, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：风湿科全球排名第一的刊。 一审17天，接收后13天online。看了看，有中国编委，中国文章也每年都有不少，中国作者可以的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Thu Aug 04 14:36:56 CST 2016, time=2016-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522639, encodeId=85c452263986, content=审稿速度:3.0 经验分享：顶级杂志，严谨求实, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Fri May 20 03:05:00 CST 2016, time=2016-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517574, encodeId=6cb251e5748d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过两篇，一篇2天就拒了，第二篇一审17天，建议大修，审稿意见很细致，改后二审20天，接收,两周后online. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=573, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95ec1668172, createdName=面膜大侠, createdTime=Mon Dec 14 09:41:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]

2015-12-14 面膜大侠

审稿速度:1.0 | 投稿命中率:25.0
经验分享：投过两篇，一篇2天就拒了，第二篇一审17天，建议大修，审稿意见很细致，改后二审20天，接收,两周后online.

573 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务